This pharmaceutical company once traded for over $100, yet it was given up for dead by most investors…until recently.
| | |
Dear Investor,
Russia continued its offensive against key Ukrainian cities this March, as a second round of talks between Moscow and Kyiv ended without a ceasefire.
The stock market also turned lower. Every major index closed negative.
Conflict creates economic chaos, and your portfolio could get totally 'wrecked' if you just stay in place and get high on the 'hope' that you'll somehow be spared…
That's why you need to look at this pharmaceutical company that once traded for over $100, yet it was given up for dead by most investors…until recently.
Now this so-called "penny stock" is on track to TRIPLE again…
I can't believe how many investors are STILL ignoring it – making it massively undervalued and a prime opportunity to get it. 
** FREE: Download this new report detailing the No. 1 "Penny Stock" pick for 2022. (**By clicking link you are subscribing to The Wealthiest Investor Newsletter and may receive up to 2 additional free bonus subscriptions. Unsubscribing is easy. Full disclosures found here.)
We're projecting this could be one of your biggest opportunities to buy low with the potential to 10x your returns this year.
It's our TOP recommended penny stock pick for 2022.
**Click here for the details and the ticker on this 'penny stock' poised to triple again. (**By clicking link you are subscribing to The Wealthiest Investor Newsletter and may receive up to 2 additional free bonus subscriptions. Unsubscribing is easy. Full disclosures found here.)
Regards,
The Wealthiest Investor Team | |
No comments:
Post a Comment